Диссертация (1141143), страница 17

Просмтор этого файла доступен только зарегистрированным пользователям. Но у нас супер быстрая регистрация: достаточно только электронной почты!

Текст из файла (страница 17)

et al. Left atrial stunningfollowing radiofrequency catheter ablation of chronic atrial flutter // J Am CollCardiol.– 1998.– Vol. 32.– p. 468–475.110. Stangier J. Clinical pharmacokinetics and pharmacodynamics of the oraldirect thrombin inhibitor dabigatran etexilate // Clin Pharmacokinet.– 2008.– Vol.

47.–p. 285–295.111. Stellbrink C., Nixdorff U., Hofmann T., Lehmacher W., Daniel W.G.,Hanrath P., Geller C., Mugge A., Sehnert W., Schmidt-Lucke C., Schmidt-Lucke J.A.,ACE (Anticoagulation in Cardioversion Using Enoxaparin) Study Group. Safety andefficacy of enoxaparin compared with unfractionated heparin and oral anticoagulantsfor prevention of thromboembolic complications in cardioversion of nonvalvular atrialfibrillation: the Anticoagulation in Cardioversion Using Enoxaparin (ACE) trial //Circulation.– 2004.– Vol. 109.– p.

997–1003.112. Stoddard M.F., Dawkins P.R., Prince C.R. et al. Left atrial appendagethrombus is not uncommon in patients with acute atrial fibrillation and a recentembolic event: a transesophageal echocardiographic study // J Am Coll Cardiol.–1995.– Vol.

25.– p. 452–459.110113. Stroke in AF working group. Independent predictors of stroke in patientswith atrial fibrillation: a systematic review // Neurology.– 2007.– Vol. 69.– p. 546–554.114. Sun H., Gaspo R., Leblanc N., Nattel S. Cellular mechanisms of atrialcontractile dysfunction caused by sustained atrial tachycardia // Circulation.– 1998.–Vol.

98.– p. 719–727.115. Tabata M.D., Oki M.D., Iuchi M.D. et al. Evaluation of left atrialappendage function by measurement of changes in flow velocity patterns afterelectrical cardioversion in patients with isolated atrial fibrillation // The Americanjournal of cardiology.– 1997.– Vol. 79.– p. 615–620.116. The Atrial Fibrillation Follow-up Investigation of Rhythm Management(AFFIRM) Investigators.

A comparison of rate control and rhythm control in patientswith atrial fibrillation // N Engl J Med.– 2002.– Vol. 347.– p. 1825–1833117. The Task Force for the Management of Atrial Fibrillation of the EuropeanSociety of Cardiology Guidelines for the management of atrial fibrillation // EuropeanHeart Journal.– 2010.– Vol. 31.– p.

2369–2429.118. Thomson R. How can epidemiological studies help us to prevent stroke?The example of atrial fibrillation. // Age Ageing.– 2002.– Vol. 31.– p. 9–16.119. Upshaw Jr. C.B. Hemodynamic changes after cardioversion of chronicatrial fibrillation // Arch Intern Med.– 1997.– Vol. 157.– p. 1070–1076.120. Van Gelder I. C., Crijins H.

J. Cardioversion of atrial fibrillation andsubsequent maintenance of sinus rhythm // PACE. – 1997. – Vol. 20. – p. 2675–2683.121. Van Gelder I., HagensV., Bosker H., Kingma J.H., Kamp O., Kingma T. etal. Comparison of rate control and rhythm control in patients with recurrent persistentatrial fibrillation // N Engl J Med.– 2002.– Vol. 347.– p.

1834–1850.122. Veinot J.P., Harrity P.J., Gentile F. et al. Anatomy of the normal left atrialappendage: a quantitative study of age-related changes in 500 autopsy hearts:implications for echocardiographic examination // Circulation.– 1997.– Vol. 96.– p.3112–3115.111123. Wang D., Liu M., Hao Z., Tao W. Association between reduced kidneyfunction and clinical outcomes after ischaemic stroke with atrial fibrillation // Eur. J.Neurol.– 2014.– Vol. 21.– p. 160–166.124. Wu L.A., Chandrasekaran K., Friedman P.A. et al. Safety of expeditedanticoagulation in patients undergoing transesophageal echocardiographic-guidedcardioversion // Am J Med.– 2006.– Vol.

119(2).– p. 142–146.125. Yadlapati A., Groh C., Passman R. Safety of short-term use of dabigatranor rivaroxaban for direct-current cardioversion in patients with atrial fibrillation andatrial flutter // Am J Cardiol.– 2014.– Vol. 113(8).– p. 1362–1363.126. Yang S., Huang C., Hu X. Predictors of left atrial appendage stunningafter electrical cardioversion of non–valvular atrial fibrillation // CMJ.– 2003.– Vol.116.– p. 1445–1450.127. Yang Y., Grosset D.G., Li Q. et al.

Identification of echocardiographic‘smoke’ in a bench model with transcranial Doppler ultrasound // Stroke.– 2000.– Vol.31.– p. 907–914.128. Yu W.C., Chen S.A., Lee S.H. et al. Tachycardia-induced change of atrialrefractory period in humans: rate dependency and effects of antiarrhythmic drugs //Circulation.– 1998.– Vol. 97.– p. 2331–2337..

Характеристики

Список файлов диссертации